Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 05 October 2015 | By Michael Mezher
The US Food and Drug Administration (FDA) is giving three duodenoscope makers 30 days to submit plans to conduct safety studies to help the agency understand the effectiveness of current cleaning instructions for these products.
In recent years, insufficient cleaning procedures have linked duodenoscopes to several bacterial outbreaks. The most notable was an outbreak of carbapenem-resistant Enterobacteriaceae (CRE) at the Ronald Reagan UCLA Medical Center in late 2014 and early 2015, which left two patients dead.
In February 2015, FDA released a safety communication warning healthcare professionals that design flaws could make these scopes difficult to clean, even if cleaning instructions are closely followed.
In May 2015, the agency's Gastroenterology-Urology Devices Panel met to discuss:
On 4 August 2015, after hearing the panel's recommendations, FDA released supplemental instructions intended to aid facilities that reprocess duodenoscopes to do so more effectively.
Shortly thereafter, on 12 August, FDA warned the three manufacturers marketing duodenoscopes in the US –Olympus, Fujifilm and Hoya – for failures related to cleaning procedures and reporting known infections.
Now, FDA is requiring the three aforementioned companies to develop postmarket surveillance studies at healthcare facilities that use their devices to assist the agency in collecting "useful data about the effectiveness of current reprocessing instructions and practices."
FDA says its investigations have shown that "reprocessing instructions are not always being followed correctly, as these instructions are labor intensive and prone to human error.”
The agency is asking the three manufacturers to answer the following questions related to their devices:
FDA says that the results of these studies should help the agency determine additional measures to reduce the risk of infection with these devices in the future.
FDA
Tags: Duodenoscope, CRE, Olympus, Fujifilm, Hoya, UCLA
Regulatory Focus newsletters
All the biggest regulatory news and happenings.